← Back to Search

Educational Intervention for HPV Vaccination (PARENT Trial)

N/A
Waitlist Available
Led By Electra Paskett
Research Sponsored by Ohio State University Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

PARENT Trial Summary

This trial looks at whether an educational intervention can increase HPV vaccination rates in younger girls in Ohio Appalachia.

Who is the study for?
This trial is for English-speaking parents in Ohio Appalachia with daughters aged 9-17 who haven't received the HPV vaccine, and healthcare providers involved in vaccinations at participating locations. Parents of vaccinated children or those outside the specified counties are excluded.Check my eligibility
What is being tested?
The study tests an educational program aimed at parents and healthcare providers to see if it increases HPV vaccination rates among young girls in Ohio Appalachia.See study design
What are the potential side effects?
Since this is an educational intervention, there are no direct medical side effects. However, participants may experience changes in knowledge or attitudes about HPV vaccination.

PARENT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of daughters of participating parents who received their first HPV vaccination
Secondary outcome measures
Proportion of daughters of participants in the intervention arm who received a second and third dose of the HPV vaccine

PARENT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I-HPV vaccine educationExperimental Treatment1 Intervention
The educational intervention is that parents and providers receive materials about HPV by mail including HPV/ cervical cancer videos and brochures, fact sheets, HPV/cervical cancer resource lists. Clinics receive posters, brochures, tabletop/reminder cards, resource lists, newsletters, and "invitation to be vaccinated" letters for parents.
Group II: Arm II- Flu vaccine educationActive Control1 Intervention
The educational intervention is that parents and providers receive materials about Flu by mail including Flu brochures, fact sheets, Flu resource lists. Clinics receive posters and brochures.

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor
320 Previous Clinical Trials
289,543 Total Patients Enrolled
Electra PaskettPrincipal InvestigatorOhio State University Comprehensive Cancer Center
2 Previous Clinical Trials
6,409 Total Patients Enrolled

Media Library

educational intervention Clinical Trial Eligibility Overview. Trial Name: NCT01901770 — N/A
Healthy Subjects Research Study Groups: Arm II- Flu vaccine education, Arm I-HPV vaccine education
Healthy Subjects Clinical Trial 2023: educational intervention Highlights & Side Effects. Trial Name: NCT01901770 — N/A
educational intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT01901770 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is registration for this research endeavor open currently?

"At the present moment, clinicaltrials.gov reports that this medical trial is not recruiting participants. The listing was first published on January 1st 2012 and last updated April 18th 2022; however there are other 949 trials presently accepting patients."

Answered by AI
~32 spots leftby Dec 2024